Clinical trial
Treatment of Pulmonary Sarcoidosis With Pentoxifylline
NCT00001877 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001877 |
|---|---|
| Title | Treatment of Pulmonary Sarcoidosis With Pentoxifylline |
| Official title | Treatment of Pulmonary Sarcoidosis With Pentoxifylline |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Sarcoidosis |
| Intervention type | Drug |
| Interventions | Pentoxifylline |
| Enrollment | 100 |
| Start date | Feb 1, 1999 |
| Completion | May 1, 2004 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: